粤海饲料(001313) - 2024 Q3 - 季度财报

Financial Performance - Revenue for the reporting period was RMB 2,090,893,322.87, a decrease of 16.37% compared to the same period last year[2] - Net profit attributable to shareholders of the listed company was RMB -19,431,335.41, a decrease of 198.12% compared to the same period last year[2] - Total revenue for the period decreased to 4,454,072,098.71 RMB from 5,317,754,468.04 RMB in the previous period, representing a decline of approximately 16.2%[22][23] - Operating profit showed a significant loss of -118,853,521.44 RMB compared to -41,007,314.08 RMB in the previous period, indicating a worsening financial performance[23] - Net profit attributable to the parent company's shareholders was -67,408,711.61 RMB, a substantial decrease from -15,190,892.61 RMB in the previous period[24] - Basic earnings per share (EPS) dropped to -0.10 RMB from -0.02 RMB, highlighting a significant decline in shareholder value[24] Assets and Liabilities - Total assets at the end of the reporting period were RMB 4,920,716,223.60, an increase of 6.16% compared to the end of the previous year[3] - Equity attributable to shareholders of the listed company was RMB 2,593,040,202.91, a decrease of 5.01% compared to the end of the previous year[3] - Total assets increased to 4,920,716,223.60 yuan from 4,635,270,233.30 yuan at the beginning of the period[19] - Total liabilities increased to 2,333,506,243.64 RMB from 1,908,528,637.44 RMB, reflecting a rise in financial obligations[21] - The company's total equity decreased to 2,587,209,979.96 RMB from 2,726,741,595.86 RMB, reflecting a reduction in shareholder equity[21] Cash Flow - Net cash flow from operating activities increased by 33.76% to -294,251,753.39, primarily due to a decrease in cash payments for goods purchased compared to the previous year[7] - Net cash flow from investing activities increased by 62.16% to -203,250,223.78, mainly due to a decrease in financial investments[7] - Net cash flow from financing activities decreased by 115.10% to -85,964,509.43, mainly due to a decrease in the amount of loans obtained and a decrease in net restricted funds compared to the same period last year[7] - Sales revenue from goods and services received in cash for the current period was 3,622,100,959.87 yuan, a decrease from the previous period's 4,751,937,222.82 yuan[25] - Net cash flow from operating activities was -294,251,753.39 yuan, an improvement from the previous period's -444,200,421.20 yuan[25] - Cash received from other operating activities increased to 32,557,434.53 yuan from 28,103,837.26 yuan in the previous period[25] - Cash paid for goods and services was 3,566,992,211.13 yuan, down from 4,787,881,866.27 yuan in the previous period[25] - Cash received from investment activities was 126,270,555.93 yuan, a significant decrease from 1,180,928,357.42 yuan in the previous period[26] - Cash paid for investment activities was 329,520,779.71 yuan, down from 1,718,071,773.09 yuan in the previous period[26] - Net cash flow from investment activities was -203,250,223.78 yuan, an improvement from -537,143,415.67 yuan in the previous period[26] - Cash received from financing activities was 634,685,921.68 yuan, down from 1,309,023,830.82 yuan in the previous period[26] - Net cash flow from financing activities was -85,964,509.43 yuan, compared to 569,191,255.79 yuan in the previous period[26] Government Subsidies and Other Income - Government subsidies received during the reporting period amounted to RMB 3,121,317.58[4] - Other income increased by 150.32% to 11,667,704.51, mainly due to an increase in government subsidies[7] Accounts Receivable and Prepayments - Accounts receivable increased by 48.37% to RMB 1,923,492,490.81 due to the peak season for business and the aquaculture cycle[6] - Prepayments increased by 217.14% to RMB 56,673,346.61 due to increased prepayments for raw materials[6] - Accounts receivable increased to 1,923,492,490.81 yuan from 1,296,431,444.89 yuan at the beginning of the period[18] - Prepayments increased to 56,673,346.61 yuan from 17,869,931.51 yuan at the beginning of the period[18] Construction and Inventory - Construction in progress increased by 198.41% to RMB 47,335,918.53 due to increased investment in workshops and factories[6] - Inventory shares increased by 127.32% to RMB 86,755,378.59 due to the company's share repurchase activities[6] - Inventory decreased to 657,945,123.11 yuan from 728,025,814.01 yuan at the beginning of the period[19] Research and Development - R&D expenses decreased by 55.56% to RMB 49,699,067.50 due to strategic adjustments in R&D[6] - Research and development expenses decreased to 49,699,067.50 RMB from 111,840,159.11 RMB, suggesting a reduction in innovation investment[23] Investment and Fair Value Changes - Investment losses increased by 170.64% to -2,396,182.18, primarily due to a decrease in gains from the termination of financial assets measured at amortized cost[7] - Fair value change losses decreased by 35.90% to 1,485,205.50, mainly due to changes in the fair value of trading financial assets[7] - Credit impairment losses increased by 49.62% to -284,689,888.77, mainly due to an increase in bad debt provisions for accounts receivable[7] Shareholders and Stock Options - The total number of ordinary shareholders at the end of the reporting period was 21,492[8] - The top shareholder, Zhanjiang Shrimp Feed Co., Ltd., holds 37.80% of the shares, totaling 264,612,000 shares[9] - The second-largest shareholder, Hong Kong Huangda Industrial Co., Ltd., holds 23.44% of the shares, totaling 164,106,000 shares[9] - 50% of the employee stock ownership plan shares were unlocked, totaling 4,250,000 shares, representing approximately 0.6071% of the company's total shares[13] - The company adjusted the exercise price of the stock options from 8.98 yuan to 8.93 yuan and canceled 5,201,600 stock options due to employee departures and unmet exercise conditions[13] Acquisitions and Terminations - The company plans to acquire 51% of I&V Bio Asia Co., Ltd. to enhance its business layout and market competitiveness[15] - The company terminated the acquisition of 70% equity in Guangzhou Xiande Biotechnology Co., Ltd. due to price discrepancies[17] Monetary Funds and Short-term Borrowings - As of September 30, 2024, the company's monetary funds decreased to 457,992,132.27 yuan from 1,081,713,391.94 yuan at the beginning of the period[18] - Short-term borrowings increased to 632,419,568.89 yuan from 562,828,162.22 yuan at the beginning of the period[20] Audit Status - The company's third-quarter report was not audited[27]